Merck KGaA (ETR:MRK - Get Free Report)'s stock price dropped 3.1% on Friday . The stock traded as low as €121.60 ($133.63) and last traded at €122.20 ($134.29). Approximately 473,666 shares were traded during mid-day trading, The stock had previously closed at €126.10 ($138.57).
Merck KGaA Trading Up 2.9 %
The company's fifty day simple moving average is €134.31 and its 200 day simple moving average is €142.95. The firm has a market capitalization of $51.66 billion, a P/E ratio of 19.06, a price-to-earnings-growth ratio of 2.37 and a beta of 0.71.
About Merck KGaA
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
See Also
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
